Savolainen V T, Pjarinen J, Perola M, Penttilä A, Karhunen P J
Department of Forensic Medicine, University of Helsinki, Finland.
Alcohol Clin Exp Res. 1996 Nov;20(8):1340-5. doi: 10.1111/j.1530-0277.1996.tb01132.x.
The present study was conducted to investigate possible association between the occurrence of glutathione-S-transferase GST M1 "null" genotype and alcoholic liver disease (ALD). The"null" genotype indicating absent activity of class mu glutathione transferase was assessed in 33 abstainers, 43 moderate alcohol consumers, and 313 heavy alcohol consumers by polymerase chain reaction. The genotypes were compared with occurrence of alcoholic fatty liver, alcoholic hepatitis, and alcoholic liver fibrosis. The "null" genotype was found among 44.7% of patients in the series, with no significant differences between different consumption groups: controls, 36.4%; moderate consumers, 39.5%; and heavy consumers, 46.3%. Occurrence of GST M1 "null" genotype was not associated with occurrence ALD among moderate alcohol consumers. Frequency of the "null" genotype was, however, statistically nearly significantly [p = 0.07, odds ratio (OR) = 1.75] lower among heavy consumers with normal liver histology than in alcoholics with ALD. Furthermore, when compared with heavy consumers without ALD, the "null" genotype was nearly significantly more frequent among heavy consumers with at least slight liver fibrosis (p = 0.05, OR = 1.8) and statistically significantly more frequent among among alcoholics with advanced liver fibrosis (p < 0.025, OR = 2.3). Results of the present Finnish association study suggest that homozygous deletion of the GST M1 gene may indicate increased susceptibility to develop irreversible liver damage in response to the toxic effects of ethanol. Significant association was found between the occurrence of the "null" genotype and the occurrence of alcoholic liver cirrhosis.
本研究旨在调查谷胱甘肽-S-转移酶GST M1“无效”基因型的出现与酒精性肝病(ALD)之间可能存在的关联。通过聚合酶链反应对33名戒酒者、43名中度饮酒者和313名重度饮酒者进行了评估,该“无效”基因型表明μ类谷胱甘肽转移酶缺乏活性。将这些基因型与酒精性脂肪肝、酒精性肝炎和酒精性肝纤维化的发生情况进行了比较。在该系列患者中,44.7%的患者存在“无效”基因型,不同饮酒组之间无显著差异:对照组为36.4%;中度饮酒者为39.5%;重度饮酒者为46.3%。在中度饮酒者中,GST M1“无效”基因型的出现与ALD的发生无关。然而,在肝脏组织学正常的重度饮酒者中,“无效”基因型的频率在统计学上几乎显著降低(p = 0.07,优势比[OR]=1.75),低于患有ALD的酗酒者。此外,与无ALD的重度饮酒者相比,至少有轻度肝纤维化的重度饮酒者中“无效”基因型的频率几乎显著更高(p = 0.05,OR = 1.8),在晚期肝纤维化的酗酒者中在统计学上显著更高(p < 0.025,OR = 2.3)。本芬兰关联研究的结果表明,GST M1基因的纯合缺失可能表明对乙醇毒性作用产生不可逆肝损伤的易感性增加。发现“无效”基因型的出现与酒精性肝硬化的发生之间存在显著关联。